Provided by Tiger Trade Technology Pte. Ltd.

Raymond James

175.20
+2.851.65%
Post-market: 175.10-0.1000-0.06%19:31 EDT
Volume:1.72M
Turnover:301.93M
Market Cap:33.66B
PE:15.27
High:176.32
Open:173.65
Low:173.63
Close:172.35
52wk High:182.73
52wk Low:138.82
Shares:192.10M
Float Shares:171.12M
Volume Ratio:1.80
T/O Rate:1.01%
Dividend:2.12
Dividend Rate:1.21%
EPS(TTM):11.47
EPS(LYR):10.30
ROE:18.42%
ROA:2.58%
PB:2.65
PE(LYR):17.01

Loading ...

Canada Stocks-TSX Rises Boosted by Miners as Choppy Week Ends

Reuters
·
Yesterday

Applied Optoelectronics Enters Equity Distribution Agreement for up to $600 Million At-the-Market Offering

Reuters
·
Yesterday

California BanCorp Initiated at Outperform by Raymond James

Dow Jones
·
Aug 21

Raymond James Adjusts PT on Ameriprise Financial to $638 From $582, Maintains Strong Buy Rating

MT Newswires Live
·
Aug 21

Raymond James Financial Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

California Bancorp initiated with an Outperform at Raymond James

TIPRANKS
·
Aug 21

Analysts’ Opinions Are Mixed on These Financial Stocks: Willis Towers Watson (WTW) and Raymond James Financial (RJF)

TIPRANKS
·
Aug 20

Raymond James Sticks to Its Buy Rating for FedEx Freight Holding Company (FDXF)

TIPRANKS
·
Aug 20

Raymond James Financial - Client Assets Under Administration Reach $1.93 Trillion, up 17% Year-over-Year as of July 31, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 20

Raymond James Assets Under Management Rise to $344.6 Billion as of July 31, 2026

Reuters
·
Aug 20

Rexford Industrial fair value estimate raised to $38 at Raymond James

TIPRANKS
·
Aug 20

Why Marvell Stock Is Rising Today and What Raymond James Sees Ahead – August 19

TIPRANKS
·
Aug 20

Safehold resumed with a Market Perform at Raymond James

TIPRANKS
·
Aug 19

Raymond James Downgrades Abercrombie & Fitch to Market Perform From Outperform

MT Newswires Live
·
Aug 18

Abercrombie & Fitch Cut to Market Perform from Outperform by Raymond James

Dow Jones
·
Aug 18

Praxis Precision price target raised to $945 from $765 at Raymond James

TIPRANKS
·
Aug 17

Rapport Therapeutics price target raised to $75 from $68 at Raymond James

TIPRANKS
·
Aug 17

Raymond James Downgrades Accelerant to Market Perform From Outperform

MT Newswires Live
·
Aug 17

Raymond James Adjusts PT on Principal Financial Group to $121 From $111, Keeps Outperform Rating

MT Newswires Live
·
Aug 17

Polaryx initiated with a Strong Buy at Raymond James

TIPRANKS
·
Aug 17